Research of the necessity of rhGH therapy on very late puberty girls with idiopathic short stature.

PAN Dan-dan,LIU Jian-hua,LU Cheng-xi,AI Rong,TONG Xue-tao,LIU Xiu-qiong.

Chinese Journal of Child Health Care ›› 2016, Vol. 24 ›› Issue (10) : 1077-7080.

PDF(597 KB)
PDF(597 KB)
Chinese Journal of Child Health Care ›› 2016, Vol. 24 ›› Issue (10) : 1077-7080. DOI: 10.11852/zgetbjzz2016-24-10-19

Research of the necessity of rhGH therapy on very late puberty girls with idiopathic short stature.

  • PAN Dan-dan,LIU Jian-hua,LU Cheng-xi,AI Rong,TONG Xue-tao,LIU Xiu-qiong.
Author information +
History +

Abstract

Objective To assess the efficacy of recombinant human growth hormone (rhGH) therapy on very late puberty girls whose bone aged 13~15.5 with idiopathic short stature (ISS) and discuss the necessary. Methods A total of 43 girls in very late puberty with ISS were divided into control group (n=15) and trial group (n=28) complying with the decision of the girls′ family.The participators in trial group were injected with rhGH 0.18~0.20 U/kg before sleep every night for 6 months,control group were observed for the same time without treatment.Bone age,growth velocity,prediction of adult height were compared between two groups.Totally 43 parents of very late puberty girls were surveyed by the self-administered questions of their own feelings about their own decision of using rhGH injection every day for a long time or not after 6 months. Results There were significant differences in growth velocity between before and after treatment in trial group (P<0.01).And after treatment with rhGH,there was significant difference of the growth velocity between two groups (P<0.01).After 6 months observation,the prediction of adult height was lower in control group,while the result was on the contrary in trial group.There were significant differences between after and before treatment of the value of the prediction of adult height between two groups (P<0.01).In the questionnaire after treatment,the curative effect and medical expense were acceptable for the parents in trial group.And the parents in control group were also calm with their decision of giving up rhGH treatment in the end. Conclusions The rhGH treatment for very late puberty girls can improve the growth velocity but can′t improve the prediction of adult height obviously.With good doctor-patient communications,the diagnosis and treatment process of these very late puberty girls with ISS leaded to a positive psychologic influence on their families both in trial group and control group after 6 months.It was suggested that weather very late puberty girls with ISS should be treated by rhGH should followed the patients′ opinion just on the basis of adequate understanding on their own condition.

Key words

idiopathic short stature / girls / recombinant human growth hormone / very late puberty / satisfaction

Cite this article

Download Citations
PAN Dan-dan,LIU Jian-hua,LU Cheng-xi,AI Rong,TONG Xue-tao,LIU Xiu-qiong.. Research of the necessity of rhGH therapy on very late puberty girls with idiopathic short stature.[J]. Chinese Journal of Child Health Care. 2016, 24(10): 1077-7080 https://doi.org/10.11852/zgetbjzz2016-24-10-19

References

[1] Cohen P.Consensus guidelines for the diagnosis and treatment of children with idiopathic short stature:A summary statement of the growth hormone research society,the lawson wilkins pediatric endocrine society and the european society for paediatric endocrinology[J].Clin Endocrinol Metab,2008,93:4210-4217.
[2] Wilson TA,Rose SR,Cohen P,et al.The lawson wilkins pediatric endocrinology society drug and therapeutics committee,update of guidelines for the use of growth hormone in children:the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee[J].Pediatr,2003,143:415-421.
[3] 中华医学会儿科学分会内分泌遗传代谢学组.矮身材儿童诊治指南[J].中华儿科杂志,2008,46(5):428-430.
[4] 中华医学会儿科学分会内分泌遗传代谢学组.基因重组人生长激素儿科临床规范应用的建议[J].中华儿科杂志,2013,51(5):426-432.
[5] Wit JM,Clayton PE,Rogol AD,et al.Idiopathic short stature:definition,epidemiology,and diagnostic evaluation[J].Growth Horm IGF Res,2008,18(2):89-110.
[6] 吴静,周娇妹,梁美娇.重组人生长激素治疗非生长激素缺乏性矮小症临床观察[J].中国基层医药,2007,14(8):1352-1353.
[7] 谢理玲,杨玉,杨利,等.重组人生长激素对青春后期特发性矮小女童促生长的疗效[J].实用儿科临床杂志,2010,25(8):598-599.
[8] 梁雁,罗小平.高度重视重组人生长激素在儿科临床的规范化应用及安全性监测[J].中华儿科杂志,2013,51(6):402.
PDF(597 KB)

Accesses

Citation

Detail

Sections
Recommended

/